More than one-fourth of new HIV infections in the United States are among persons aged 13 to 24 years, and most of them aren't even aware.
Phase 3 data show effectiveness of somapacitan in children with growth disorders
Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates.
Food Insecurity and the Dangers of Infant Formula Dilution
INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients
Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial.
Demystifying Infant Formula
FDA seeks to remove ingestible fluoride products for children
The administration has set a goal date of October 31 to complete a safety review, public comment period, and to take "appropriate action" in efforts to remove products from the market.
FDA starts review of nutrients in infant formula
According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."